home our story events blog neuroblastoma media links shop contact us DONATE
chasing charlie’s cure

from stage 4 high-risk neuroblastoma

Details of the vaccine trial can be found here.

A journal article published in 2014 presenting outcomes of relapsed patients treated with the vaccine at Memorial Sloan Kettering Cancer Center (MSKCC):

Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission

Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Kim Kramer, Govind Ragupathi and Nai-Kong V. Cheung

2018 Update from MSKCC about their vaccine and other immunotherapy treatment (skip the first 25mins)

Band of Parents, helping to fund MSKCC’s vital work.

Vaccine Therapy…


Sign-up for updates Find us on Social Media